Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

NorwayBack to Norway

Clinical trials in Bodo – page 3

36 clinical trials in Bodo, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Bodo at a glance
36
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

36 trials in Bodo

Open in trial search

Type IIa hyperlipidaemia

Not recruiting

Study of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Idiopathic pulmonary fibrosis

Not recruiting

Study on the Effects of CAL101 for Patients with Idiopathic Pulmonary Fibrosis

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:CAL101
  • Sponsor:Calluna Pharma AS

Hypercholesterolaemia

Not recruiting

Study on the Safety and Efficacy of MK-0616 for Adults with High Cholesterol

InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Enlicitide Chloride
  • Sponsor:Merck Sharp & Dohme LLC

Plasma cell myeloma

Not recruiting

Study on Early Treatment for Multiple Myeloma Relapse Using Carfilzomib, Bortezomib, Daratumumab, Lenalidomide, and Dexamethasone in Patients with MRD Negativity

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Oslo University Hospital HF

Lung neoplasm malignant

Not recruiting

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Domvanalimab
  • Sponsor:AstraZeneca AB

Rheumatoid arthritis

Not recruiting

Study on Monitoring Adalimumab for Maintaining Disease Control in Adults with Rheumatoid Arthritis

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Adalimumab
  • Sponsor:Diakonhjemmet Sykehus AS

Type IIa hyperlipidaemia

Not recruiting

Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Sharp & Dohme LLC

Migraine

Not recruiting

Study on Botulinum Toxin Type A for Patients with Treatment-Resistant Chronic Migraine

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:St. Olavs Hospital HF

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Type IIa hyperlipidaemia

Not recruiting

Study of MK-0616 for Adults with Familial Hypercholesterolemia

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Enlicitide Chloride
  • Sponsor:Merck Sharp & Dohme LLC

Small cell lung cancer extensive stage

Not recruiting

Study on the Effect of Adding Thoracic Radiotherapy to Durvalumab and Chemotherapy for Patients with Extensive Stage Small-Cell Lung Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology

Psoriasis

Not recruiting

Study on the Effectiveness and Safety of HRO350 for Patients with Mild-to-Moderate Psoriasis

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Pehero
  • Sponsor:Arctic Bioscience AS

Other cities in Norway

The busiest research cities in the country

All 54 cities in Norway

Clinical research in Bodo

What the registry says about research in the country

01 Respiratory Medicine

Research focusing on pulmonary diseases and respiratory conditions, including studies on treatment approaches for idiopathic pulmonary fibrosis and advanced lung cancer therapies.

  • Pulmonary Fibrosis Treatment Studies
  • Small-Cell Lung Cancer Therapy
  • Pediatric Respiratory Infections

Clinical trials evaluating innovative treatments combining immunotherapy with conventional approaches.

02 Cardiovascular Research

Comprehensive studies addressing cardiovascular disorders, from stroke prevention to cholesterol management and acute cardiac conditions.

  • Stroke Prevention in Atrial Fibrillation
  • Acute Myocardial Infarction Management
  • Cholesterol Control Therapies

Innovative approaches in preventive cardiology and acute cardiac care interventions.

03 Oncology Studies

Advanced cancer research including precision medicine trials for various cancer types, with particular focus on melanoma and breast cancer treatments.

  • Pancreatic Cancer Therapies
  • Advanced Melanoma Treatment
  • HER2-Positive Breast Cancer

Pioneering targeted therapies and immunotherapy approaches for cancer treatment.

04 Chronic Conditions

Research addressing long-term health conditions including rheumatoid arthritis, chronic kidney disease, and obesity management.

  • Adolescent Obesity Treatment
  • Chronic Kidney Disease
  • Arthritis Management

Focus on developing effective long-term treatment strategies for chronic conditions.

Back to NorwayAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.